stockrow
Saturday 7 November 2026
Export MVIS’s income statement to Excel — free account
Microvision, Inc.
MVIS Technology Scientific & Technical Instruments
Microvision, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 million, down 74.3% from fiscal 2024.
- Revenue
- +895.9%
- EPS
- +40.0%
- Free cash flow
- +9.71%
- Total debt
- −54.8%
Quarter to September 2026, against a year earlier
1.16
0.02
+1.75%
Follow MVIS
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
187.31 | 127.44 | 38.04 | 8.17 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(14.69) | (12.04) | (5.71) | (3.01) | |
P/B ratio |
4.07 | 5.01 | 5.30 | 1.81 | |
Price to Tangible BV |
4.08 | 8.92 | 33.53 | 7.19 | |
EV/Sales |
124.98 | 97.47 | 28.41 | 2.38 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(2.57) | (2.48) | (1.21) | (0.18) | |
EV/FCF |
(2.54) | (2.45) | (1.19) | (0.18) | |
Quick Ratio |
2.50 | 0.91 | 0.57 | 0.65 | |
Current Ratio |
2.69 | 1.05 | 0.68 | 0.80 | |
Net Debt/EBITDA |
2.75 | 2.53 | 1.76 | 1.76 | |
Debt/Assets |
0.03% | 0.02% | 0.02% | 0.02% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.01 | 0.01 | 0.03 | 0.04 | |
Operating CF/Net income |
0.41 | 0.65 | 0.52 | 1.12 | |
Capex/Depreciation |
(0.02) | (0.03) | (0.04) | (0.28) | |
Interest Coverage |
(32.84) | (8.53) | (4.42) | (11.19) | |
Research and Development Expense of Revenue |
3,892.83% | 1,544.92% | 1,065.99% | 549.17% | |
Selling, General and Administrative Expense of Revenue |
1,428.25% | 1,017.22% | 625.32% | 389.96% | |
Intangible Assets out of Total Assets |
0.00 | 0.16 | 0.20 | 0.19 | |
Share Based Compensation of Revenue |
(693.72%) | 105.13% | 88.53% | 48.42% | |
Graham Net Nets |
0.15 | (0.08) | (0.31) | (0.74) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(42.25%) | (48.31%) | (110.37%) | (340.57%) | |
Free Cash Flow Yield |
(26.25%) | (31.20%) | (62.52%) | (162.33%) | |
Revenue per Share |
0.01 | 0.05 | 0.07 | 0.09 | |
Operating CF per Share |
(0.85) | (0.80) | (0.86) | (0.50) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.05) | |
Free Cash Flow per Share |
(0.86) | (0.81) | (0.87) | (0.55) | |
Cash per Share |
4.13 | 2.26 | 1.24 | 1.06 | |
Shareholders Equity per Share |
3.05 | 1.92 | 0.92 | 0.83 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.05 | 1.92 | 0.92 | 0.83 | |
Free Cash Flow |
(15.65) | (16.59) | (19.45) | (15.00) | |
Working Capital |
50.96 | 2.46 | (16.14) | (9.29) | |
Capital Expenditures |
(0.24) | (0.14) | (0.30) | (1.37) | |
Net Current Asset Value |
33.54 | (16.44) | (33.70) | (30.23) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
1.09 | 0.15 | 0.21 | 0.57 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.49 | 0.49 | 0.51 | 0.72 | |
Average Payables |
1.38 | 2.90 | 3.72 | 3.85 | |
Average Inventory |
1.52 | 3.28 | 4.89 | 6.27 | |
Average Assets |
112.14 | 113.47 | 114.61 | 120.83 | |
Average Common Equity |
52.16 | 46.37 | 48.86 | 56.73 |
Columns are period end dates · fundamentals updated 6 Nov 2026